Canine Pyometra: A Uterine Disorder of Clinical Importance
Commonly affecting intact female dogs during the diestrus phase, pyometra is a possibly fatal inflammatory uterine infection. It is frequently caused by hormonal imbalances, especially prolonged progesterone dominance after repeated estrous cycles, and is characterized by an accumulation of purulent material within the uterine lumen. The disorder is frequently preceded by cystic endometrial hyperplasia (CEH), which affects uterine defense, glandular production, and endometrial proliferation. The illness usually affects middle-aged to older bitches, and its symptoms can range from abdominal distension and vaginal discharge to systemic symptoms that include fever, lethargy, polyuria, and polydipsia. Clinical examination, hematological and biochemical profile, and imaging techniques including ultrasonography which shows intraluminal fluid accumulation and uterine enlargement are the basis for the diagnosis.Other opportunistic bacteria may be involved; however, Escherichia coli is the most commonly isolated pathogen. Antibiotics, supportive therapy, and either medical or surgical management are all necessary components of treatment. Hormonal therapy involving antiprogestins (e.g., aglepristone), prostaglandins, and dopamine agonists (e.g., cabergoline or bromocriptine) have been used successfully in certain cases, although ovariohysterectomy is still the final treatment. When compared to monotherapy, combination protocols especially those that combine aglepristone and prostaglandin have demonstrated enhanced efficacy, with treatment success of varying extent. In order to lower mortality and maintain reproductive function when desirable, early diagnosis and suitable therapeutic intervention are crucial
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-10-11
- DOI
- https://doi.org/10.5281/zenodo.17327002
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00